DNASense

Aalborg, Denmark Founded: 2014 • Age: 12 yrs Acquired By Clinical Microbiomics
Genetic engineering services including sequencing and metagenomics are provided.

About DNASense

DNASense is a Healthcare company based in Aalborg (Denmark) founded in 2014 by Mads Albertsen, and was acquired by Clinical Microbiomics in March 2024. Genetic engineering services including sequencing and metagenomics are provided. The company has 8 employees. Its chief executive, as recorded, is Mads Albertsen. DNASense offers products and services including Microbial marker gene analysis, Genomics, Metagenomics, Metatranscriptomics, and Microbial source tracking. Its focus areas include Life Sciences, Genomics, Genomics Services and Full Service. Its legal entity is DNASENSE APS.

Company details

DNASense was established in 2014 in Aalborg, Denmark, within the biotechnology sector. Genetic engineering services are delivered by the company, covering bacteria and archaea community profiling, fungi community profiling, sequencing, metagenomics, bioinformatics analysis, gene expression profiling, and biobank operations. These activities support research and analysis in microbial and genetic fields across various applications.

  • Headquarters Aalborg, Denmark
  • Employees 8
  • Founders Mads Albertsen
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website dnasense.com
  • Social LinkedIn X
  • Acquired by Clinical Microbiomics (Mar 2024)
  • Legal Name Dnasense Aps
Key Metrics

Products & Services of DNASense

DNASense offers a comprehensive portfolio of products and services, including Microbial marker gene analysis, Genomics, Metagenomics, Metatranscriptomics, and Microbial source tracking.

Microbial marker gene analysis
Genomics Service

Targeted sequencing to identify microbial communities and their abundance.

Genomics
DNA Sequencing

Provides annotated microbial genomes for metabolic potential analysis.

Metagenomics
Community Analysis

Whole-genome sequencing to uncover microbial community structures.

Metatranscriptomics
Transcript Analysis

RNA sequencing for quantifying transcripts in microbial samples.

Microbial source tracking
Contamination Service

Sequencing to track and pinpoint sources of microbial outbreaks.

Publication support package
Support Service

Assists with data sharing and figure customization for publications.

Investors in DNASense

DNASense has secured backing from 1 investor. Prominent investors backing the company include Clinical Microbiomics.

All
InvestorDescriptionFounded YearDomainLocation
Meta-genomics platforms and services for microbiome studies are provided.
2016clinical-microbiomics.comHorsholm, Denmark
Premium access

Investor details for DNASense

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of DNASense

1 people are tracked at DNASense (1 in leadership); the tracked headcount is 8.

NameRoleGroup
Mads Albertsen
Co-Founder & CEOLeadership
Premium access

Complete people profiles for DNASense

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of DNASense

2 dated milestones of DNASense across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded DNASense is founded.
  2. Exit Acquired by Clinical Microbiomics.

Web traffic of DNASense

The website of DNASense (dnasense.com) receives about 2.7K visits a month.

  • Monthly visits
    2.7K

    ▲ 9.3% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Dnasense

Premium access

Complete news archive for DNASense

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about DNASense

DNASense was founded in 2014.

DNASense is headquartered in Aalborg, Denmark.

Mads Albertsen is the CEO of DNASense, as recorded in our data. They have also founded this company.

DNASense has 8 employees.

DNASense was established in 2014 in Aalborg, Denmark, within the biotechnology sector. Genetic engineering services are delivered by the company, covering bacteria and archaea community profiling, fungi community profiling, sequencing, metagenomics, bioinformatics analysis, gene expression profiling, and biobank operations. These activities support research and analysis in microbial and genetic fields across various applications.

DNASense offers Microbial marker gene analysis, Genomics, Metagenomics, Metatranscriptomics, and 2 more products and services.

DNASense has 1 investor. Key investors include Clinical Microbiomics.

DNASense operates through Dnasense Aps.

Yes. DNASense was acquired by Clinical Microbiomics in March 2024.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available